Latest News and Press Releases

New York, May 06, 2024 (GLOBE NEWSWIRE) -- Overview The Global Neurological Disorder Drugs Market size is expected to reach USD 66.4 billion by 2024 and is further anticipated to reach USD...

Pune, Jan. 18, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Neurological Disorder Drugs Market is expected to clock US$ 88.07 billion by 2031...

Newark, New Castle, USA, July 02, 2023 (GLOBE NEWSWIRE) -- A recent report by Growth Plus Reports estimated the global neurological disorder drugs market to be worth US$ 60.1 billion in 2022. From...

London, March 06, 2023 (GLOBE NEWSWIRE) -- Neurological disorders have been among the leading causes of mortality worldwide. Although a majority of neurological conditions predominantly tends to...

Wilmington, Delaware, United States, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – By 2031, the AI in drug discovery market size is estimated to surpass value of US$ 10.93...

NEW YORK, Sept. 19, 2022 (GLOBE NEWSWIRE) -- A Qualitative Research Study accomplished by Data Bridge Market research's database of 350 pages, titled as “Global Neurological Disorder Drugs Market”...

Increase in number of patients suffering from disorders, such as multiple sclerosis, Parkinson’s disease, cerebrovascular diseases, Alzheimer’s disease, and epilepsy is bolstering the market ALBANY,...

Visiongain has published a new report on Neurological Disorder Drugs Market Report 2021-2031: Forecasts By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic,...